🎉 NMPA Approval!
#Bireociclib Tablets (#Xuan Yuening) by #Xuanzhu Biopharmaceutical Co., Ltd. are now approved for HR+/HER2– advanced or metastatic breast cancer.

📧 info@dengyuemed.com
#CDK46Inhibitor #HRPositiveBreastCancer #HER2NegativeBreastCancer #NMPAApproval
#HongKongDengYueMedicine

New pill can slow progression of incurable breast cancer Around 3,000 women a year with advanced cancer could benefit from capivasertib which can slow the disease.

#oncology #breastcancer #NHS #capivasertib #Truqap #AstraZeneca #targetedtherapy #AKT #AKTinhibitors #ATKKinases #HRpositivebreastcancer #HER2negativebreastcancer #PIK3CAgene #AKT1gene #PTENgene #NICE #NICEguidance #genetictesting #BreastCancerNow
www.bbc.co.uk/news/article...

Stephanie Graff: Excited to have another therapeutic option to treat advanced HR+ breast cancer - OncoDaily Stephanie Graff: Excited to have another therapeutic option to treat advanced HR+ breast cancer / Breast Cancer, cancer, Datopotumab deruxtecan, FDA, HR+

Excited to have another therapeutic option to treat advanced HR+ breast cancer - Stephanie Graff
@drsgraff.bsky.social
@fda.gov

oncodaily.com/insight/step...

#BreastCancer #Cancer #DatopotumabDeruxtecan #FDA #HRpositiveBreastCancer #OncoDaily #Oncology #Health #TargetedOncology #Medicine